Literature DB >> 21926108

14-3-3σ and p63 play opposing roles in epidermal tumorigenesis.

Qiutang Li1, Sumitha A T Sambandam, Helen J Lu, Alexander Thomson, Sung-hye Kim, Huayi Lu, Ying Xin, Qingxian Lu.   

Abstract

14-3-3σ plays a regulatory role in epidermal epithelial differentiation and loss of 14-3-3σ leads to increased proliferation and impaired differentiation. A tumor suppressor function for 14-3-3σ has been proposed based on the fact that some epithelial-derived tumors lose 14-3-3σ expression. p63, a p53 family member, is a master regulator of epidermal epithelial proliferation and differentiation and is necessary for the epidermal development. The function of p63 in tumorigenesis is still controversial and poorly defined as multiple isoforms have been found to play either collaborative or opposing roles. By using 'repeated epilation' heterozygous (Er/+) mice containing a dominant-negative 14-3-3σ mutation, the functional relationship of p63 with 14-3-3σ in epidermal proliferation, differentiation and tumorigenesis was investigated. It was found that p63, particularly the ΔNp63α isoform, was strongly expressed in 14-3-3σ-deficient keratinocytes and knockdown of p63 remarkably inhibited proliferation in these cells. To study the functional roles of 14-3-3σ and p63 in epidermal tumorigenesis, we adopted a 7,12-dimethylbenzanthracene/12-O-tetradecanoyl-phorbol-13-acetate (DMBA/TPA) two-stage tumorigenesis procedure to induce formation of skin papillomas and squamous cell carcinomas in Er/+ mice and identified strong p63 expression in resultant tumors. The loss of one allele of p63 caused by the generation of Er/+/p63(+/-) double compound mice decreased the sensitivity to DMBA-/TPA-induced tumorigenesis as compared with Er/+ mice. This study shows that p63 and 14-3-3σ play opposing roles in the development of skin tumors and that the accumulation of p63 is essential for Ras/14-3-3σ mutation-induced papilloma formation and squamous cell carcinoma carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21926108      PMCID: PMC3220605          DOI: 10.1093/carcin/bgr207

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  35 in total

1.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development.

Authors:  A Yang; R Schweitzer; D Sun; M Kaghad; N Walker; R T Bronson; C Tabin; A Sharpe; D Caput; C Crum; F McKeon
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

2.  p63 is a p53 homologue required for limb and epidermal morphogenesis.

Authors:  A A Mills; B Zheng; X J Wang; H Vogel; D R Roop; A Bradley
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

3.  RACK1 and stratifin target DeltaNp63alpha for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage.

Authors:  Alexey Fomenkov; Rachel Zangen; Yi-Ping Huang; Motonobu Osada; Zhongmin Guo; Tanya Fomenkov; Barry Trink; David Sidransky; Edward A Ratovitski
Journal:  Cell Cycle       Date:  2004-10-06       Impact factor: 4.534

4.  Increased sensitivity to two-stage skin carcinogenesis of mice heterozygous for the repeated epilation mutation (Er).

Authors:  A L Reddy; P J Fialkow
Journal:  Int J Cancer       Date:  1990-11-15       Impact factor: 7.396

5.  High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?

Authors:  T Crook; J M Nicholls; L Brooks; J O'Nions; M J Allday
Journal:  Oncogene       Date:  2000-07-13       Impact factor: 9.867

6.  14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage.

Authors:  T A Chan; H Hermeking; C Lengauer; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1999-10-07       Impact factor: 49.962

7.  Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder.

Authors:  Fumitaka Koga; Satoru Kawakami; Yasuhisa Fujii; Kazutaka Saito; Yukihiro Ohtsuka; Aki Iwai; Noboru Ando; Touichiro Takizawa; Yukio Kageyama; Kazunori Kihara
Journal:  Clin Cancer Res       Date:  2003-11-15       Impact factor: 12.531

8.  Analysis of 14-3-3sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma.

Authors:  Dimitri Lodygin; Amir S Yazdi; Christian A Sander; Thomas Herzinger; Heiko Hermeking
Journal:  Oncogene       Date:  2003-08-21       Impact factor: 9.867

9.  14-3-3sigma is a p53-regulated inhibitor of G2/M progression.

Authors:  H Hermeking; C Lengauer; K Polyak; T C He; L Zhang; S Thiagalingam; K W Kinzler; B Vogelstein
Journal:  Mol Cell       Date:  1997-12       Impact factor: 17.970

10.  DeltaNp63 induces beta-catenin nuclear accumulation and signaling.

Authors:  Meera Patturajan; Shuji Nomoto; Matthias Sommer; Alexey Fomenkov; Kenji Hibi; Rachel Zangen; Nina Poliak; Joseph Califano; Barry Trink; Edward Ratovitski; David Sidransky
Journal:  Cancer Cell       Date:  2002-05       Impact factor: 31.743

View more
  11 in total

1.  Targeted deletion and lipidomic analysis identify epithelial cell COX-2 as a major driver of chemically induced skin cancer.

Authors:  Jing Jiao; Tomo-O Ishikawa; Darren S Dumlao; Paul C Norris; Clara E Magyar; Carol Mikulec; Art Catapang; Edward A Dennis; Susan M Fischer; Harvey R Herschman
Journal:  Mol Cancer Res       Date:  2014-07-25       Impact factor: 5.852

2.  Forward genetics identifies Kdf1/1810019J16Rik as an essential regulator of the proliferation-differentiation decision in epidermal progenitor cells.

Authors:  Sunjin Lee; Yong Kong; Scott D Weatherbee
Journal:  Dev Biol       Date:  2013-09-25       Impact factor: 3.582

3.  KDF1, encoding keratinocyte differentiation factor 1, is mutated in a multigenerational family with ectodermal dysplasia.

Authors:  Hanan E Shamseldin; Ola Khalifa; Yousef M Binamer; Abdulmonem Almutawa; Stefan T Arold; Hamad Zaidan; Fowzan S Alkuraya
Journal:  Hum Genet       Date:  2016-11-12       Impact factor: 4.132

4.  Expression of Hsp90α and cyclin B1 were related to prognosis of esophageal squamous cell carcinoma and keratin pearl formation.

Authors:  Tingyuan Huang; Size Chen; Hongyu Han; Huadan Li; Zhizhou Huang; Jianming Zhang; Qiangbin Yin; Xiaojie Wang; Xiaojiao Ma; Peijuan Dai; Danping Duan; Fei Zou; Xuemei Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

Review 5.  The role of barrier genes in epidermal malignancy.

Authors:  C Darido; S R Georgy; S M Jane
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

6.  14-3-3σ regulates keratinocyte proliferation and differentiation by modulating Yap1 cellular localization.

Authors:  Sumitha A T Sambandam; Ramesh B Kasetti; Lei Xue; Douglas C Dean; Qingxian Lu; Qiutang Li
Journal:  J Invest Dermatol       Date:  2015-02-10       Impact factor: 8.551

7.  Deletion of 14-3-3σ sensitizes mice to DMBA/TPA-induced papillomatosis.

Authors:  Markus Winter; Dmitri Lodygin; Berlinda Verdoodt; Heiko Hermeking
Journal:  Oncotarget       Date:  2016-07-26

8.  Delineating Molecular Mechanisms of Squamous Tissue Homeostasis and Neoplasia: Focus on p63.

Authors:  Kathryn E King; Linan Ha; Tura Camilli; Wendy C Weinberg
Journal:  J Skin Cancer       Date:  2013-04-22

9.  Mouse Genetic Models Reveal Surprising Functions of IkB Kinase Alpha in Skin Development and Skin Carcinogenesis.

Authors:  Xiaojun Xia; Eunmi Park; Susan M Fischer; Yinling Hu
Journal:  Cancers (Basel)       Date:  2013-02-15       Impact factor: 6.639

10.  PKK suppresses tumor growth and is decreased in squamous cell carcinoma of the skin.

Authors:  Brian Poligone; Elaine S Gilmore; Carolina V Alexander; David Oleksyn; Kathleen Gillespie; Jiyong Zhao; Sherrif F Ibrahim; Alice P Pentland; Marc D Brown; Luojing Chen
Journal:  J Invest Dermatol       Date:  2014-10-06       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.